In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Part of paid clinical trials in Little Rock, Arkansas.

Sponsor
University of Arkansas
Study ID
NCT05301348
Status
Recruiting
Apply to this trial

Conditions

  • Thromboembolism

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Photoacoustic Flow Cytometry — DEVICE
    Detection of circulating blood clots

Study Details

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

Key Dates

Start date
Jul 26, 2023
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Jan 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Procedure
    Subjects will receive PAFC procedure

Primary Outcome Measure

Comparison of Circulating blood clots detected by PAFC with D-dimer levels in patients with known venous thromboembolic disease - Positive PA peaks [ Time Frame: 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Univerisity of Arkansas for Medical SciencesLittle RockArkansas72205
Sanjeeva Onteddu, M.D.
[email protected]
501-686-5135

Find similar trials in Little Rock, AR

By research site
Univerisity of Arkansas for Medical Sciences· Little Rock, AR

Related Studies